

Episode 89: Can Good Drug Policy Survive 2025?
Jan 10, 2025
The discussion dives into the chaotic landscape of drug policy as we approach 2025. Hosts reflect on rising overdose rates and the alarming emergence of drugs like xylazine. They critique the lasting impact of political agendas on harm reduction efforts while celebrating recent advancements in methadone regulations driven by activism. The conversation also spotlights the stigma surrounding overdose prevention sites and acknowledges the unsung heroes advocating for change. Hope and resilience shine through as they emphasize the power of community-led initiatives.
AI Snips
Chapters
Transcript
Episode notes
Overdose Decline Factors
- Overdose deaths decreased slightly in 2024, but not due to drug war tactics.
- Reduced fentanyl purity, xylazine's rise, and cartel instability all played a role.
User-Led Drug Checking
- Drug checking programs, run by drug users, are crucial for understanding overdose trends.
- Direct user input is vital, as external analysis is often guesswork.
Fifth Wave?
- The drug crisis may be entering a fifth wave, shifting towards sedatives like xylazine.
- This challenges the traditional framework of opioid and stimulant waves.